Biblioteca CRAI Dulce Chacón - Universidad Europea de Madrid

CRAI Library - Madrid
Your cart is empty.
My folder ( items) | My account
Image from Google Jackets

Molecular Vaccines / edited by Matthias Giese

Contributor(s): Giese, Matthias, editor literario
Material type: materialTypeLabelE-bookPublisher: Cham, Switzerland : Springer International Publishing International Publishing, 2014Description: 1 recurso en línea (XXVIII, 870 páginas) : 98 ilustraciones, 74 ilustraciones en color.ISBN: 9783319009780.Subject: VacunasDDC classification: 615.372 Online resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)Digital Resources
Partial contents:
From Prophylaxis to Therapy
Abstract: This title discusses all aspects of non-infectious and non-cancer- so called NINC - vaccines. Hypertension, diabetes and allergy vaccine development are referred to as well as the use of adjuvants and nanotechnology in vaccine development. The way of novel vaccines from bench to preclinical to clinical studies and launch to the market under EMEA (European Medicines Agency) and FDA (Food and Drug Administration) guidelines are described in-depth. The book is therefore of interest for researchers and clinicians engaged in vaccine development and molecular vaccine application.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Collection Call number Copy number Status Date due Barcode Item holds
LIBRO-E NO PRÉSTAMO LIBRO-E NO PRÉSTAMO Madrid Digital Acceso Electrónico (UEM) Ciencias de la Salud RM281 .M65 2014 EB (Browse shelf(Opens below)) .i11547479 Acceso electrónico eBOOK .i11547479
Total holds: 0

Volumen 2 . From Prophylaxis to Therapy

This title discusses all aspects of non-infectious and non-cancer- so called NINC - vaccines. Hypertension, diabetes and allergy vaccine development are referred to as well as the use of adjuvants and nanotechnology in vaccine development. The way of novel vaccines from bench to preclinical to clinical studies and launch to the market under EMEA (European Medicines Agency) and FDA (Food and Drug Administration) guidelines are described in-depth. The book is therefore of interest for researchers and clinicians engaged in vaccine development and molecular vaccine application.

There are no comments on this title.

to post a comment.
Share